President and Founder Ariadne Software, LLC Lawrence, Kansas
10:30 AM – 11:00 AM ET
Update on Bioanalytical Method Validation for Hybrid Assays in Regulated Studies Faye Vazvaei, M.S. – Merck & Co., Inc.
11:00 AM – 11:30 AM ET
An Industry Perspective of Evolving Strategies and Key Focus Areas in Metabolite Bioanalysis Wenkui Li, Ph.D. – Novartis Institutes for BioMedical Research, Inc.
11:30 AM – 12:00 PM ET
Strategy to Replace Quantitation of Nucleoside Phosphates in Pbmcs by Indirect Quantitation in Human Dried Blood Using Volumetric Absorptive Microsampling Cynthia M. Chavez-Eng, Ph.D. – Merck & Co., Inc.
12:00 PM – 12:30 PM ET
Bioanalytical Laboratory Automation: Where We Came From, Where We Are ,and Where We Are Going? Jim Shen, Ph.D. – Bristol-Myers Squibb Company